OpenAI Revenue Hits $50 Billion, Below Earlier $70 Billion Estimate 
Zcash Privacy Demand Rises as AI Exposes Bitcoin Transactions 
Oracle Uses Trucked Natural Gas to Power AI Data Centers Amid Pipeline Delays 
Jameson Lopp Downplays AI Threat to Bitcoin Cryptography 
EU Gives Crypto Platforms Three Months to Remove USDT Under MiCA Rules 
MSTR Stock Rises as Barclays Raises Price Target to $175 
Rapidus Seeks Chip Customers as Japan Pushes 2nm Semiconductor Revival 
Robinhood Chain Eyes Priority Gas Auctions for Faster Trades 
Europol Warns Bitcoin Wallets Face Quantum Computing Risk 
OpenAI Annualized Revenue Hits $50 Billion, Below Earlier Estimates 
Trump Buys Up to $25M in Meta Stock, Invests in SpaceX Debt 
Samsung Q3 Profit Hits Record High on AI Memory Demand 
DogecoinVM Makes DOGE Transactions 300x Faster 
Zcash Plans Quantum-Resistant Security Upgrade for January 
US Suspends Microsoft, Adobe From Green Card Program 
Amazon Cuts More Jobs as AI Investment Expands 
Moscow Exchange to Launch Crypto Trading on December 1 
Add as a preferred source on Google
Samsung Electonics’ Galaxy smartwatches are being put in the spotlight after a recent study shows it can help people suffering from Parkinson’s disease. It was revealed on Wednesday, Sept. 15, that the smart gadget’s blood pressure monitoring feature is very useful for patients.
The Samsung Galaxy smartwatches are equipped with various health and fitness features and its blood pressure monitoring was especially found to be beneficial. According to Yonhap News Agency, a study was conducted at the Samsung Medical Center based in Seoul, and researchers found that the BP function in the watch may help people with Parkinson’s disease in terms of effective management of orthostatic hypotension which is a type of low blood pressure typically brought about by blood vessels that failed to constrict.
The study led by Dr. Jin Whan Cho and Dr. Jong Hyeon Ahn has been titled the “Validation of Blood Pressure Measurement Using a Smartwatch in Patients With Parkinson's Disease,” and it was published in Frontiers in Neurology, a medical journal for research reports, in June.
In the report, researchers were said to have compared blood pressure measurement data taken from the Samsung Galaxy Watch3 and the other was measured by using a sphygmomanometer. This was done to compare the accuracy of the results and it showed that both devices yielded similar measurements.
“Orthostatic hypotension is a common and challenging symptom that affects people living with PD. But it is hard to screen just by observing symptoms, and the problem may go undetected when measuring BP,” the research team said in a separate press release that was posted by Samsung. “If we could use a smartwatch to measure patients’ BP regularly and detect potential issues at an early stage, it would really help treat and manage PD.”
The study was carried with the participation of 56 patients who were fitted with Galaxy Watch3 on one arm while the sphygmomanometer was put on the other. All the patients underwent blood measure testing three times, using the two devices.
Meanwhile, Samsung’s smartwatches lineup including Galaxy Watch3, Galaxy Watch Active2, and Galaxy Watch4 all have a blood pressure monitoring feature. The BP is being measured through pulse wave analysis that is tracked with Heart Rate Monitoring sensors.
